Back to search

Article

The CD8⁺T/MDSC ratio: A novel prognostic and predictive biomarker for immunotherapy response in gastric cancer

2026-04-14

Abstract excerpt

<title>Abstract</title> <p>Background Immune imbalance in tumor microenvironment is closely linked to GC progression. MDSCs primarily drive immune imbalance by suppressing the anti-tumor activity of CD8⁺T cells. Notably, no prior study has explored the combination of CD8⁺T cells and MDSCs to assess the clinical prognosis or immunotherapy response in GC. Methods PubMed and EMBASE were searched, literature screen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
edbabb46-2d11-5d5f-85e8-1b3a3c7fd01d
DOI
10.21203/rs.3.rs-9286398/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The CD8⁺T/MDSC ratio: A novel prognostic and predictive biomarker for immunotherapy response in gastric cancerDOI 10.21203/rs.3.rs-9286398/v1
Select a neighboring publication to make it the new centre.